JONATHAN TRAHAN: Open Payments
NPI 1326584822 · CARRIERE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 31 payments from 14 companies in 2025. Trend: 2023 $235 · 2024 $671 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $110 |
| Lilly USA, LLC | 6 | $99 |
| Corcept Therapeutics | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| Novo Nordisk Inc | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
Products named: MOUNJARO, Korlym, LEQVIO, UBRELVY, VOQUEZNA, FARXIGA, BEVESPI AEROSPHERE, GVOKE HYPOPEN.
Industry payments across MS — which companies pay providers there.
